ITGB1 and neoplasm: Notably, several ligand-receptor pairs associated with tumor progression were identified between fibroblasts and immune cells, including FN1-(ITGA8+ITGB1), FN1-CD44, COL4A2-CD44, and ANGPTL1-(ITGA8+ITGB1) (Figure 3D).